IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 321 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $789,000 | -41.2% | 13,178 | -36.9% | 0.02% | -38.2% |
| Q2 2019 | $1,342,000 | -46.7% | 20,886 | -32.7% | 0.03% | -46.9% |
| Q1 2019 | $2,519,000 | +50.2% | 31,028 | 0.0% | 0.06% | +48.8% |
| Q4 2018 | $1,677,000 | -9.8% | 31,028 | -13.9% | 0.04% | -4.4% |
| Q3 2018 | $1,859,000 | +15.8% | 36,035 | -6.5% | 0.04% | +18.4% |
| Q2 2018 | $1,606,000 | -31.9% | 38,538 | -28.0% | 0.04% | -36.7% |
| Q1 2018 | $2,358,000 | -29.9% | 53,488 | -20.0% | 0.06% | -31.0% |
| Q4 2017 | $3,362,000 | -19.8% | 66,842 | -19.1% | 0.09% | -19.4% |
| Q3 2017 | $4,190,000 | -0.9% | 82,635 | -0.6% | 0.11% | -10.7% |
| Q2 2017 | $4,228,000 | – | 83,105 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |